Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-08-13
2009-06-09
Kolker, Daniel E. (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07544659
ABSTRACT:
The present invention concerns a method of promoting axonal regeneration. In particular, the invention concerns a method of promoting the growth or regeneration of neurons, and treating disease or conditions associated with the loss, loss of function or dysfunction of nerve cells, in particular thalamic nerve cells, by administering a polypeptide having a high degree of sequence identity with a native sequence Netrin G1 (NGL-1) or an agonist thereof.
REFERENCES:
patent: 6036957 (2000-03-01), Weiner et al.
patent: 6252040 (2001-06-01), Warren et al.
patent: 2006/0194210 (2006-08-01), Morris
patent: 99/14328 (1999-03-01), None
patent: 99/20644 (1999-04-01), None
patent: 99/63088 (1999-12-01), None
patent: 00/15796 (2000-03-01), None
patent: 00/73454 (2000-12-01), None
patent: 01/04311 (2001-01-01), None
patent: 01/68848 (2001-09-01), None
Kandel et al. 1991 Principles of Neural Science, pp. 258-265.
van Ham 2003. Molecular Biology Reports 30:69-82.
Bradl 2003. J Neurol Neurosurg Psychiatry 74:1364-1370.
Deumens 2002. Experimental Neurology 175:303-317.
Cluskey et al. 2001. Mol Pathol 54:386-392.
Hoffner et al 2002. Biochimie 84:273-278.
Lin 2003. Nature Neuroscience 6:1270-1276.
Gonsette, 2004. Expert Opin Pharmacother. 5(4):747-765.
Winer, 2002. Q J Med 95:717-721.
Mittoux 2002. J Neurosci 22:4478-4486.
Saykin, 2004. Brain 127:1574-1583.
Schenk 1999. Nature 400:173-177.
Yuki 2001. Annals of Neurology 49:712-720.
Leegwater-Kim 2004. NeuroRx 1:128-138.
Shastry 2003. Neurochemistry International 43:1-4).
Bates 2003. Curr Opin Neurol 16:465-470.
Braisted, et al., “Thalamocortical Axons are Influenced by Chemorepellent and Chemoattractant Activities Localized to Decision Points Along Their Path”, Developmental Biology, vol. 208, pp. 430-440, (1999).
Hamelin, et al., “Expression of the UNC-5 Guidance Receptor in the Touch Neurons ofC. ElegansSteers their Axons Dorsally”, Nature, vol. 364, pp. 327-330, (1993).
Hedgecock, et al., “The UNC-5, UNC-6, and UNC—40 Genes Guide Circumferential Migrations of Pioneer Axons and Mesodermal Cells on the Epidermis inC. Elegans”, Neuron, vol. 2, pp. 61-85, (1990).
Ishii, et al., “UNC-6, A Laminin-Related Protein, Guides Cell and Pioneer Axon Migrations inC. Elegans”, Neuron, vol. 9, pp. 873-881, (1992).
Keino-Masu, et al., “Deleted in Colorectal Cancer (DCC) Encodes a Netrin Receptor”, Cell, vol. 87, pp. 175-185, (1996).
Lee, et al., “IL-17E, A Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1”, The Journal of Biological Chemistry, vol. 276, No. 2, pp. 1660-1164, (2001).
Leonardo, et al., “Vertebrate Homologues ofC. ElegansUNC-5 are Candidate Netrin Receptors”, Nature, vol. 386, pp. 833-838, (1997).
Metin, et al., “The Ganglionic Eminence May Be an Intermediate Target for Corticofugal and Thalamocortical Axons”, The Journal of Neuroscience, vol. 16, No. 10, pp. 3219-3235, (1996).
Nakashiba, et al., “Netrin-G1: A Novel Glycosyl Phosphatidylinositol-Linked Mammalian Netrin That is Functionally Divergent from Classical Netrins”, The Journal of Neuroscience, vol. 20, No. 17, pp. 6540-6550, (2000).
Serafini, et al., “The Netrins Define a Family of Axon Outgrowth-Promoting Proteins Homologous toC. ElegansUNC-6”, Cell, vol. 78, pp. 409-424, (1994).
Yin, et al., “Laminets: Laminin-and Netrin-Related Genes Expressed in Distinct Neuronal Subsets”, Molecular and Cellular Neuroscience, vol. 19, pp. 344-358, (2002).
Bagri, et al., “Slit Proteins Prevent Midline Crossing and Determine the Dorsoventral Position of Major Axonal Pathways in the Mammalian Forebrain”, Neuron, vol. 33, pp. 233-248, (2002).
Gold et al., Journal of Neuroimmunology 138: 99-105 (2003).
Villoslada et al. J. Exp. Med. 191:1799-1866 (2000).
Linker et al. Nat. Med. 6: 620-624 (2002).
Bensa et al., Eur. J. Neurol. 7(4):423-6 (2000).
Birecree et al., Journal of Neuropathology and Experimental Neurology: 47(5); pp. 549-560 (1988).
Klein et al., Brain. Res. 875:144-151 (2000).
Holtzman, et al, “Selective Inhibition of Axon Outgrowth by Antibodies to NGF in a Model to Temporal Lobe Epilepsy”, The Journal of Neuroscience, 15(11): 7062-7070, (1995).
McDonald, et al, “A model for a glutamate receptor agonist antibody-binding site”, Journal of Molecular Recognition, vol. 12, pp. 219-225, (1999).
Steiner, et al, “Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models”, Proc. Natl. Acad. Aci., vol. 94, pp. 2019-2024, (1997).
Lin John (Chia-Yang)
Rosenthal Arnon
Dreger Ginger R.
Elliott Jennifer L.
Fox James A.
Genentech Inc.
Kolker Daniel E.
LandOfFree
Promotion of axonal regeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Promotion of axonal regeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promotion of axonal regeneration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4085343